Filtered By:
Condition: Thrombosis
Management: National Health Service (NHS)

This page shows you your search results in order of date.

Order by Relevance | Date

Total 6 results found since Jan 2013.

China stroke surveillance report 2021
AbstractSince 2015, stroke has become the leading cause of death and disability in China, posing a significant threat to the health of its citizens as a major chronic non-communicable disease. According to the China Stroke High-risk Population Screening and Intervention Program, an estimated 17.8 million [95% confidence interval (CI) 17.6 –18.0 million] adults in China had experienced a stroke in 2020, with 3.4 million (95% CI 3.3–3.5 million) experiencing their first-ever stroke and another 2.3 million (95% CI 2.2–2.4 million) dying as a result. Additionally, approximately 12.5% (95% CI 12.4–12.5%) of stroke survi...
Source: Military Medical Research - July 19, 2023 Category: International Medicine & Public Health Source Type: research

Forgetting “routine” deep venous thrombosis and stroke during COVID-19 is a parallel pandemic that will be costly if ignored
The current COVID-19 pandemic has resulted in a huge strategic and clinical change within the UK National Health Service (NHS) to ensure that it can cope with the surge in demand of respiratory patients. However, when attention is acutely shifted, routine care will suffer and that could be deadly for some and enormously expensive for the NHS in the long term. Fig, A, shows the increasing public interest over time relating to COVID-19 search terms in the Google Trends health category for the United Kingdom (UK) over the last 30  days.
Source: Journal of Vascular Surgery - April 29, 2020 Category: Surgery Authors: Steven K. Rogers, Michael Hughes Source Type: research

Combining transcranial ultrasound with intelligent communication methods to enhance the remote assessment and management of stroke patients: Framework for a technology demonstrator
With over 150,000 strokes in the United Kingdom every year, and more than 1 million living survivors, stroke is the third most common cause of death and the leading cause of severe physical disability among adults. A major challenge in administering timely treatment is determining whether the stroke is due to vascular blockage (ischaemic) or haemorrhage. For patients with ischaemic stroke, thrombolysis (i.e. pharmacological ‘clot-busting’) can improve outcomes when delivered swiftly after onset, and current National Health Service Quality Improvement Scotland guidelines are for thrombolytic therapy to be provid...
Source: Health Informatics Journal - August 8, 2016 Category: Information Technology Authors: Mort, A., Eadie, L., Regan, L., Macaden, A., Heaney, D., Bouamrane, M.-M., Rushworth, G., Wilson, P. Tags: Articles Source Type: research

Impact On Italian National Health Service Expenditure For The Treatment Of Venous Thromboembolism With Rivaroxaban
This study aims to evaluate the economic impact of the use of rivaroxaban for preventing DVT and PE in Italy.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Roggeri, DP Roggeri, V Pengo Source Type: research

A Hidden Danger In The New Versions Of Birth Control Pills
Women who take a newer version of birth control pills have a doubled risk of developing potentially fatal blood clots, according to a new study published in the British medical journal BMJ. Venous thromboembolism is a serious condition that encompasses both deep vein thrombosis -- when a person develops a blood clot in the legs -- and pulmonary embolism, in which the clot travels to the lungs and obstructs breathing. VTE is potentially fatal, and the study indicates that women who take combined oral contraceptives with newer progesterone formulations are two times more likely to develop it as opposed to women who take a ...
Source: Science - The Huffington Post - May 27, 2015 Category: Science Source Type: news

Adverse outcomes after total and unicompartmental knee replacement in 101 330 matched patients: a study of data from the National Joint Registry for England and Wales
Publication date: 18–24 October 2014 Source:The Lancet, Volume 384, Issue 9952 Author(s): Alexander D Liddle , Andrew Judge , Hemant Pandit , David W Murray Background Total knee replacement (TKR) or unicompartmental knee replacement (UKR) are options for end-stage osteoarthritis. However, comparisons between the two procedures are confounded by differences in baseline characteristics of patients undergoing either procedure and by insufficient reporting of endpoints other than revision. We aimed to compare adverse outcomes for each procedure in matched patients. Methods With propensity score techniques, we compared ma...
Source: The Lancet - October 17, 2014 Category: Journals (General) Source Type: research